IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 1 biotech developing antibody cancer immunotherapies in China.
Industry: Health Care
Latest Trade: $2.39 0.00 (0.0%)
First Day Return: +57.8%
Return from IPO: -87.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/19/2021 |
Offer Price | $19.00 |
Price Range $17.00 - $19.00 | |
Offer Shares (mm) | 7.4 |
Deal Size ($mm) | $140 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/08/2021 |
Offer Price | $19.00 |
Price Range $17.00 - $19.00 | |
Offer Shares (mm) | 7.4 |
Deal Size ($mm) | $140 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Goldman Sachs (Asia) |
Morgan Stanley |
more |
Company Data | |
---|---|
Headquarters | Suzhou, China |
Founded | 2011 |
Employees | 198 |
Website www.adagene.com |